Brief: Moberg Pharma Receives Approval From The EMA's Paediatric Committee

Moberg Pharma AB (publ)

22/09/2021 07:05

Sept 22 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA RECEIVES APPROVAL FROM THE EMA'S PAEDIATRIC
COMMITTEE
    * RECEIVED APPROVAL OF PEDIATRIC PLAN FOR MOB-015 FROM EMA'S
PAEDIATRIC COMMITTEE (PDCO)
    * APPROVAL ENABLES COMPANY TO PURSUE A FULL MARKETING
AUTHORIZATION APPLICATION PROVIDING UP TO TEN YEARS OF
EXCLUSIVITY IN EUROPE FOLLOWING APPROVAL
    * COMPANY'S TIMELINE REMAINS, WITH PLANNED SUBMISSION FOR
MOB-015
IN EUROPE THIS YEAR AND EXPECTED MARKET APPROVAL IN 2023

Source text for Eikon:  ID:nWkr3CpSbp 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))